EMA Authorised: Tecvayli — Janssen-Cilag International N.V.

View source ↗

Summary

The EMA has authorised Tecvayli (Janssen-Cilag) for multiple myeloma under conditional approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TECVAYLI (TECLISTAMAB-CQYV)

Snippet

Status: Authorised. Therapeutic area: Multiple Myeloma. MAH: Janssen-Cilag International N.V.. Decision date: 26/05/2026. Conditional approval